These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32025570)

  • 1. Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with uncomplicated
    Birgersson S; Valea I; Tinto H; Traore-Coulibaly M; Toe LC; Hoglund RM; Van Geertruyden JP; Ward SA; D'Alessandro U; Abelö A; Tarning J
    Wellcome Open Res; 2019; 4():45. PubMed ID: 32025570
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso.
    Valea I; Tinto H; Traore-Coulibaly M; Toe LC; Lindegardh N; Tarning J; Van Geertruyden JP; D'Alessandro U; Davies GR; Ward SA
    J Antimicrob Chemother; 2014 Sep; 69(9):2499-507. PubMed ID: 24891429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
    van der Pluijm RW; Tripura R; Hoglund RM; Pyae Phyo A; Lek D; Ul Islam A; Anvikar AR; Satpathi P; Satpathi S; Behera PK; Tripura A; Baidya S; Onyamboko M; Chau NH; Sovann Y; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Chutasmit K; Saelow C; Runcharern R; Kaewmok W; Hoa NT; Thanh NV; Hanboonkunupakarn B; Callery JJ; Mohanty AK; Heaton J; Thant M; Gantait K; Ghosh T; Amato R; Pearson RD; Jacob CG; Gonçalves S; Mukaka M; Waithira N; Woodrow CJ; Grobusch MP; van Vugt M; Fairhurst RM; Cheah PY; Peto TJ; von Seidlein L; Dhorda M; Maude RJ; Winterberg M; Thuy-Nhien NT; Kwiatkowski DP; Imwong M; Jittamala P; Lin K; Hlaing TM; Chotivanich K; Huy R; Fanello C; Ashley E; Mayxay M; Newton PN; Hien TT; Valecha N; Smithuis F; Pukrittayakamee S; Faiz A; Miotto O; Tarning J; Day NPJ; White NJ; Dondorp AM;
    Lancet; 2020 Apr; 395(10233):1345-1360. PubMed ID: 32171078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
    Saito M; Carrara VI; Gilder ME; Min AM; Tun NW; Pimanpanarak M; Viladpai-Nguen J; Paw MK; Haohankhunnatham W; Konghahong K; Phyo AP; Chu C; Turner C; Lee SJ; Duanguppama J; Imwong M; Bancone G; Proux S; Singhasivanon P; White NJ; Nosten F; McGready R
    BMC Med; 2021 Jun; 19(1):132. PubMed ID: 34107963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria.
    Zani B; Gathu M; Donegan S; Olliaro PL; Sinclair D
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD010927. PubMed ID: 24443033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.
    Smithuis F; Kyaw MK; Phe O; Win T; Aung PP; Oo AP; Naing AL; Nyo MY; Myint NZ; Imwong M; Ashley E; Lee SJ; White NJ
    Lancet Infect Dis; 2010 Oct; 10(10):673-81. PubMed ID: 20832366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
    Tarning J; Kloprogge F; Piola P; Dhorda M; Muwanga S; Turyakira E; Nuengchamnong N; Nosten F; Day NP; White NJ; Guerin PJ; Lindegardh N
    Malar J; 2012 Aug; 11():293. PubMed ID: 22913677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite malaria and pregnancy effect on oral bioavailability of artesunate - a population pharmacokinetic evaluation.
    Kloprogge F; McGready R; Phyo AP; Rijken MJ; Hanpithakpon W; Than HH; Hlaing N; Zin NT; Day NP; White NJ; Nosten F; Tarning J
    Br J Clin Pharmacol; 2015 Oct; 80(4):642-53. PubMed ID: 25877779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
    Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
    Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four Artemisinin-Based Treatments in African Pregnant Women with Malaria.
    ; Pekyi D; Ampromfi AA; Tinto H; Traoré-Coulibaly M; Tahita MC; Valéa I; Mwapasa V; Kalilani-Phiri L; Kalanda G; Madanitsa M; Ravinetto R; Mutabingwa T; Gbekor P; Tagbor H; Antwi G; Menten J; De Crop M; Claeys Y; Schurmans C; Van Overmeir C; Thriemer K; Van Geertruyden JP; D'Alessandro U; Nambozi M; Mulenga M; Hachizovu S; Kabuya JB; Mulenga J
    N Engl J Med; 2016 Mar; 374(10):913-27. PubMed ID: 26962727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
    Smithuis F; Kyaw MK; Phe O; Aye KZ; Htet L; Barends M; Lindegardh N; Singtoroj T; Ashley E; Lwin S; Stepniewska K; White NJ
    Lancet; 2006 Jun; 367(9528):2075-85. PubMed ID: 16798391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
    Tarning J; Rijken MJ; McGready R; Phyo AP; Hanpithakpong W; Day NP; White NJ; Nosten F; Lindegardh N
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1997-2007. PubMed ID: 22252822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics and pharmacodynamics of the artesunate-mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children.
    Guidi M; Mercier T; Aouri M; Decosterd LA; Csajka C; Ogutu B; Carn G; Kiechel JR
    Malar J; 2019 Apr; 18(1):139. PubMed ID: 30999915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria.
    Morris CA; Onyamboko MA; Capparelli E; Koch MA; Atibu J; Lokomba V; Douoguih M; Hemingway-Foday J; Wesche D; Ryder RW; Bose C; Wright L; Tshefu AK; Meshnick S; Fleckenstein L
    Malar J; 2011 May; 10():114. PubMed ID: 21548983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar.
    Lohy Das JP; Kyaw MP; Nyunt MH; Chit K; Aye KH; Aye MM; Karlsson MO; Bergstrand M; Tarning J
    Malar J; 2018 Mar; 17(1):126. PubMed ID: 29566683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
    Hoglund RM; Adam I; Hanpithakpong W; Ashton M; Lindegardh N; Day NP; White NJ; Nosten F; Tarning J
    Malar J; 2012 Nov; 11():398. PubMed ID: 23190801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria.
    McGready R; Stepniewska K; Ward SA; Cho T; Gilveray G; Looareesuwan S; White NJ; Nosten F
    Eur J Clin Pharmacol; 2006 May; 62(5):367-71. PubMed ID: 16552504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial.
    Sirima SB; Ogutu B; Lusingu JPA; Mtoro A; Mrango Z; Ouedraogo A; Yaro JB; Onyango KO; Gesase S; Mnkande E; Ngocho JS; Ackermann I; Aubin F; Vanraes J; Strub N; Carn G
    Lancet Infect Dis; 2016 Oct; 16(10):1123-1133. PubMed ID: 27430374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.